UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002547
Receipt number R000003113
Scientific Title Laparoscopy-assisted distal gastrectomy versus open distal gastrectomy. A prospective randomized single-blind study
Date of disclosure of the study information 2009/09/25
Last modified on 2009/09/25 16:54:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Laparoscopy-assisted distal gastrectomy versus open distal gastrectomy. A prospective randomized single-blind study

Acronym

LADG vs. Open distal gastrectomy- randomized single-blind trial

Scientific Title

Laparoscopy-assisted distal gastrectomy versus open distal gastrectomy. A prospective randomized single-blind study

Scientific Title:Acronym

LADG vs. Open distal gastrectomy- randomized single-blind trial

Region

Japan


Condition

Condition

gastric cancer

Classification by specialty

Surgery in general Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to evaluate differences in postoperative physical activity between laparoscopy assisted distal gastrectomy (LADG) and open distal gastrectomy (ODG).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary endpoint of the study was comparison of physical activity between the LADG and ODG groups using Active tracer.

Key secondary outcomes

The secondary endpoints were various postoperative surgical parameters, duration of pain control, times of pain rescue and visual analog pain scale.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

open distal gastrectomy (ODG)

Interventions/Control_2

laparoscopy assisted distal gastrectomy (LADG)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

The inclusion criteria were age between 20 and 80 years, performance status of ECOG 0-1, signed informed consent, location of the primary tumor in the antrum, angle and lower body, histologically confirmed adenocarcinoma of the stomach with preoperative staging of stage IA or IB

Key exclusion criteria

The exclusion criteria were metastatic disease, previous history of malignancy in any organ, any co-morbidity obviating major surgery, contraindication to laparoscopy such as severe cardiac disease, abdominal wall hernias, portal hypertension, pregnancy, previous upper abdominal major surgery excluding appendectomy and laparoscopic cholecystectomy, complicated cases requiring emergency surgery, and an accompanying surgical condition requiring surgery at the same time.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shuji Takiguchi

Organization

Graduate School of Medicine, Osaka University

Division name

Division of Gastroenterological Surgery

Zip code


Address

2-2 E2 Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3251

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Graduate School of Medicine, Osaka University

Division name

Division of Gastroenterological Surgery

Zip code


Address


TEL

06-6879-3251

Homepage URL


Email



Sponsor or person

Institute

Division of Gastroenterological Surgery, Graduate School of Medicine, Osaka University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2002 Year 08 Month 16 Day

Date of IRB


Anticipated trial start date

2003 Year 07 Month 01 Day

Last follow-up date

2006 Year 01 Month 01 Day

Date of closure to data entry

2009 Year 04 Month 01 Day

Date trial data considered complete

2009 Year 05 Month 01 Day

Date analysis concluded

2009 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 09 Month 25 Day

Last modified on

2009 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003113


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name